BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 220417)

  • 21. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
    Barnette MS; Manning CD; Price WJ; Barone FC
    J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New fluorescent analogs of cAMP and cGMP available as substrates for cyclic nucleotide phosphodiesterase.
    Hiratsuka T
    J Biol Chem; 1982 Nov; 257(22):13354-8. PubMed ID: 6292187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in phosphodiesterase activity in the developing rat submandibular gland.
    Tanaka S; Shimooka S; Shimomura H
    Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta.
    Lindgren S; Rascón A; Andersson KE; Manganiello V; Degerman E
    Biochem Pharmacol; 1991 Jul; 42(3):545-52. PubMed ID: 1650216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of membrane-bound cyclic nucleotide phosphodiesterases from bovine aortic smooth muscle.
    Ivorra MD; Le Bec A; Lugnier C
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):532-40. PubMed ID: 1380595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peptide-activator of cyclic nucleotide phosphodiesterases in the rat and human uterus].
    Garnovskaia MN; Savitskiĭ GA
    Ukr Biokhim Zh (1978); 1989; 61(4):100-3. PubMed ID: 2555944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclic 3':5'-nucleotide phosphodiesterase in human myometrium at the end of pregnancy: partial purification and characterization of the different soluble isoenzymes.
    Leroy MJ; Pichard AL; Cabrol D; Ferre F
    Gynecol Obstet Invest; 1985; 20(1):27-36. PubMed ID: 2995211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta.
    Ahn HS; Crim W; Romano M; Sybertz E; Pitts B
    Biochem Pharmacol; 1989 Oct; 38(19):3331-9. PubMed ID: 2554921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ; Maurice DH
    Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme assays for cGMP hydrolyzing phosphodiesterases.
    Rybalkin SD; Hinds TR; Beavo JA
    Methods Mol Biol; 2013; 1020():51-62. PubMed ID: 23709025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
    Bode DC; Kanter JR; Brunton LL
    Circ Res; 1991 Apr; 68(4):1070-9. PubMed ID: 1849058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDE2 at the crossway between cAMP and cGMP signalling in the heart.
    Weber S; Zeller M; Guan K; Wunder F; Wagner M; El-Armouche A
    Cell Signal; 2017 Oct; 38():76-84. PubMed ID: 28668721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential inhibition of cyclic AMP and cyclic GMP hydrolysis in rat renal cortex.
    Zenser TV; Craven PA; DeRubertis FR; Davis BB
    Arch Biochem Biophys; 1977 Jan; 178(2):598-606. PubMed ID: 189700
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B; Mantell K; Bacher B
    Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Properties of cyclic nucleotide phosphodiesterase from plasma membranes of rat synaptosomes at early stages of acute radiation injury].
    Parkhomets TI; Vasil'ev AN; Kucherenko NE
    Ukr Biokhim Zh (1978); 1988; 60(3):25-30. PubMed ID: 2842904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of cGMP-induced relaxation and cGMP-dependent protein kinase in rat myometrium during pregnancy.
    Word RA; Cornwell TL
    Am J Physiol; 1998 Mar; 274(3):C748-56. PubMed ID: 9530107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.